Roughly one in ten adults carries a penicillin-allergy label. When tested, the overwhelming majority — well above 90 percent — do not have a true allergy. The label persists from a childhood rash, a vague family history, or a documentation error decades ago. It quietly affects how that patient is treated for every infection, surgery, and hospitalisation thereafter.
Why so many labels are wrong
The most common origin story is a rash that appeared during a course of amoxicillin in childhood. In a child with an underlying viral illness (the actual reason for the antibiotic), the rash was almost certainly viral. It got blamed on the antibiotic, the family was told to avoid penicillin for life, and the label stayed on the chart forever.
Other common origins:
- Side effects (nausea, headache, diarrhoea) mistakenly recorded as allergy
- A grandparent's reaction generalised to "the family is allergic"
- An allergic reaction in childhood that was real — but that the patient has now outgrown (most childhood penicillin allergies fade within 10 years)
Why the label matters
Carrying a penicillin-allergy label is not a benign inconvenience. Documented downstream consequences include:
- Treatment with broader-spectrum, less effective, more expensive alternative antibiotics
- Higher rates of Clostridioides difficile infection
- Higher rates of MRSA and vancomycin-resistant enterococcus carriage
- Higher rates of surgical site infection
- Longer hospital stays and higher healthcare costs
- Suboptimal antibiotic choice in pregnancy, where penicillins are usually preferred
Antibiotic stewardship organisations now actively recommend de-labelling as a routine part of medical care.
What the de-labelling work-up involves
The work-up is usually completed in a single specialist appointment. Steps typically include:
- Detailed clinical history. Age at the original reaction, timing relative to the dose, the nature of the reaction (rash, swelling, breathing difficulty), whether any similar reactions have occurred since, and what antibiotics the patient has tolerated in the meantime.
- Risk stratification. Reactions are categorised as high-risk (anaphylaxis, Stevens-Johnson syndrome), intermediate-risk (typical hives within hours of dose), or low-risk (delayed mild rash, GI side effects, vague history).
- Skin testing. For appropriate candidates, skin prick and intradermal testing with major and minor penicillin determinants. Takes about 90 minutes.
- Oral challenge. For most low-risk and intermediate-risk patients with negative skin testing (or directly for clearly low-risk histories), an observed dose of amoxicillin given in clinic. The patient is monitored for 1 to 2 hours.
A negative challenge means the label can be removed. Most patients walk out of the clinic with a confirmed-tolerant note for their chart.
Who should be assessed?
- Anyone who has carried a penicillin-allergy label since childhood without a confirmed serious reaction
- Patients planning surgery, immunosuppression, or fertility treatment
- Women planning pregnancy — penicillins are usually first-line for many obstetric infections
- Patients on multiple antibiotics for recurrent infections
- Anyone whose chart label is causing repeated workarounds in care
What to expect from a specialist visit
A drug-allergy assessment is a focused, predictable encounter. Plan for 2 to 3 hours total if skin testing and challenge are both done. Eat normally beforehand; bring your full medication list; bring whatever family history you can. Most patients leave the appointment without the label they came in with.
Our Allergy Rapid Access Clinic sees most referred patients within the same week. De-labelling is among the most worthwhile investigations we offer.